Drugs / gpASIT+TM
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01506375 | Nov 2011 → Jan 2013 | seasonal allergic rhinitis | BioTech Tools S.A. | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | gpASIT+TM | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01506375 ↗ |
| Modality | Peptide | “gpASIT+TM (grass pollen peptides)” NCT01506375 ↗ |
| Route | Subcutaneous | “1 subcutaneous injection every 7 days during 29 days” NCT01506375 ↗ |